跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PR-21
首页
药物
PR-21
PR-21
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
CN 103224495 B
申请人: GUERBET SA
优先权: 2005
CN
EP
4 件公开
Method for selective preparation of aryl 5-thio-beta-D-aldohexopyranosides
US 7250522 B2
申请人: TAISHO PHARMACEUTICAL CO LTD
优先权: 2002
EP
US
3 件公开
Enediyne conjugates
US 11547763 B2
申请人: SYNAFFIX BV
优先权: 2017
CN
US
3 件公开
NEW MICROCAPSULES CONTAINING ACTIVE SUBSTANCES
EP 4049749 A1
申请人: BASF SE
优先权: 2021
CN
EP
2 件公开
21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) and its use as medicament for treating excess of glucocorticoids
US 6303591 B1
申请人: APPLIED RESEARCH SYSTEMS
优先权: 1997
US
Contraceptive regimens of progesterone receptor antagonists and kits
CN 1980660 A
申请人: WYETH CORP
优先权: 2004
CN
Progesterone receptor antagonists, contraceptive regimens, and kits
US 2006009509 A1
申请人: WYETH CORP
优先权: 2005
US
5-aryl isoxazolines for controlling invertebrate pests
CN 101331127 B
申请人: DU PONT
优先权: 2006
CN
Antitumor pharmaceutical composition
CN 109394786 A
申请人: XIAN JIAOTONG LIVERPOOL UNIV
优先权: 2018
CN
Chinese herbal medicine oral tablet for preventing and curing various kinds of lymphoma and preparation method thereof
CN 110507763 A
申请人: LI MINGJIE
优先权: 2019
CN
药物
反馈